Form 8-K - Current report:
SEC Accession No. 0001193125-14-131698
Filing Date
2014-04-04
Accepted
2014-04-04 16:01:33
Documents
5
Period of Report
2014-03-31
Items
Item 2.02: Results of Operations and Financial Condition
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d706848d8k.htm 8-K 20953
2 EX-99.1 d706848dex991.htm EX-99.1 30069
3 EX-99.2 d706848dex992.htm EX-99.2 5775
4 GRAPHIC g706848ex99_1logo.jpg GRAPHIC 9632
5 GRAPHIC g706848ex99_2logo.jpg GRAPHIC 9632
  Complete submission text file 0001193125-14-131698.txt   84982
Mailing Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879
Business Address 401 PROFESSIONAL DRIVE, SUITE 250 GAITHERSBURG MD 20879 240-243-1201
GLYCOMIMETICS INC (Filer) CIK: 0001253689 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36177 | Film No.: 14745931
SIC: 2834 Pharmaceutical Preparations